У нас вы можете посмотреть бесплатно A Once-a-Month GLP-1? Pfizer is Working On it ! или скачать в максимальном доступном качестве, видео которое было загружено на ютуб. Для загрузки выберите вариант из формы ниже:
Если кнопки скачивания не
загрузились
НАЖМИТЕ ЗДЕСЬ или обновите страницу
Если возникают проблемы со скачиванием видео, пожалуйста напишите в поддержку по адресу внизу
страницы.
Спасибо за использование сервиса ClipSaver.ru
Pfizer may not be first in GLP-1s, but they are clearly not sitting this one out. In this video, Christopher Durham breaks down what we learned directly from Pfizer’s recent analyst presentation and Q&A about their obesity strategy, including the development of a potential once-a-month GLP-1 and how the company plans to compete in a market currently led by Novo Nordisk and Eli Lilly. This is not about hype or headlines. It is about listening carefully to what Pfizer’s executives actually said about their pipeline, their priorities, and their long-term plan in obesity care and translating what that could mean for real patients. As part of our ongoing series looking at the earnings and analyst calls shaping the future of obesity treatment, this episode focuses on Pfizer’s position, their timeline, and the role they believe they can play in expanding access and options for patients who are using GLP-1s to treat the disease of obesity. Christopher also shares his perspective as someone who began his GLP-1 adventure in September 2023 and has lost over 100 pounds, maintaining today at 185. Like many of you, he and Laraine have paid out of pocket for every dose. Access and affordability are not theoretical issues in this conversation. They are lived reality. As always, Christopher is not a doctor and this video is not medical advice. If you are considering a GLP-1, speak with your healthcare provider. If you are new to our channel, The Downsized is where we talk openly about treating the disease of obesity with GLP-1s including Zepbound, Mounjaro, Wegovy, and Ozempic and the real-world impact these medications are having on our lives. Subscribe and follow along as we continue breaking down the strategies, decisions, and innovations that could shape the next era of obesity care. +++++++++++++++++++++++++++++++++++++++ Get your Hume BodyPod today and use our exclusive Downsized code for up to 50% total savings! 👉 Use our Code: THEDOWNSIZED Link to purchase: https://humehealth.com//discount/THED... Start your weight loss journey today! We use Mochi Health: https://app.joinmochi.com/eligibility... Use Laraine’s code for $40 off: QIYGO8. Me Again Iphone GLP-1 App: https://apps.apple.com/us/app/meagain... AMAZON GLP-1 Companion Product Store: https://www.amazon.com/shop/downsized As an Amazon Associate, I earn from qualifying purchases. DOWNSIZED LINKS Website: https://thedownsized.org Be our guest on The Downsized Dish: apply at https://thedownsized.org/downsized-dish/ Https://Thedownsized.Org/ Book The Downsized At Sea Cruise 2026: Https://Thedownsized.Org/Downsized-At... FOR SPONSORSHIPS, BRAND DEALS & COLLABS: https://thedownsized.org/contact/ +++++++++++++++++++++++++++++++++++++++ 00:00 Intro 01:49 Understanding the Earnings Calls 02:40 Pfizer's Market Position and Future Plans 03:13 The Importance of Obesity in Pfizer's Strategy 04:06 Pfizer's Financial Overview 08:00 The Science Behind Pfizer's GLP-1 Program 09:52 Global Market and Patient Impact 11:29 Pfizer's Broader Obesity Pipeline 15:41 Long-Term Vision and Sustainability 20:52 Conclusion and Next Steps